Gene · 1285
Papers2,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| JMJD6-driven epigenetic activation of COL4A2 reprograms glioblastoma vascularization via integrin α1β1-dependent PI3K/MAPK signaling. | Acta Neuropathol Commun | 2025 | 40993804 | PubTator, text mining | PubMed |
| The microenvironment of ocular surface in keratoconus: a systematic review. | Eye Vis (Lond) | 2025 | 40993744 | PubTator, text mining | PubMed |
| Targeted exome sequencing for molecular diagnosis of pediatric Alport syndrome in Southwest China. | Front Genet | 2025 | 40949880 | PubTator, text mining | PubMed |
| Pathogenic synonymous variation of the COL4A3 gene causing Alport syndrome comorbid with IgA deposition in a toddler: a case report. | BMC Nephrol | 2025 | 40866801 | PubTator, text mining | PubMed |
| Novel COL4A3-COL4A5 variants and digenic inheritance in pediatric Alport syndrome from Southwestern China. | Sci Rep | 2025 | 40855356 | PubTator, text mining | PubMed |
| Case Report: Whole genome sequencing identifies a novel deep intronic COL4A5 variant of uncertain significance in X-linked Alport syndrome. | Front Pediatr | 2025 | 40852417 | PubTator, text mining | PubMed |
| Lithuanian Study on COL4A3 and COL4A4 Genetic Variants in Alport Syndrome: Clinical Characterization of 52 Individuals from 38 Families. | Int J Mol Sci | 2025 | 40806767 | PubTator, text mining | PubMed |
| Importance of family history and health checkup for school-aged children for type IV collagen-associated nephropathy in hereditary kidney disease. | J Nephrol | 2025 | 40753325 | PubTator, text mining | PubMed |
| Collagen IV in Gould syndrome and Alport syndrome. | Nat Rev Nephrol | 2025 | 40745060 | PubTator, text mining | PubMed |
| Characterization of Monogenic Kidney Disease in Older Patients With CKD. | Kidney Int Rep | 2025 | 40677324 | PubTator, text mining | PubMed |
| Estimating Lifetime Risk of Autosomal Recessive Kidney Diseases Using Population-Based Genotypic Data. | Kidney Int Rep | 2025 | 40677321 | PubTator, text mining | PubMed |
| Transcriptional Insights into Anti-Adhesion of Human Milk Oligosaccharides Against E. coli O157:H7: Decoy Effects and Immunomodulatory. | J Agric Food Chem | 2025 | 40613459 | PubTator, text mining | PubMed |
| Collagen Type IV Variants and Kidney Cysts: Decoding the COL4A Puzzle. | Genes (Basel) | 2025 | 40565535 | PubTator, text mining | PubMed |
| The complexity of kidney disease secondary to collagen IV variants: insights into phenotypic variability from a large Sicilian pedigree. | J Nephrol | 2025 | 40522375 | PubTator, text mining | PubMed |
| Familial Kidney Disease Phenocopying Hypertensive Nephropathy. | Glomerular Dis | 2025 | 40492141 | PubTator, text mining | PubMed |
| Molecular dynamics simulations of intrinsically disordered protein regions enable biophysical interpretation of variant effect predictors. | bioRxiv | 2025 | 40462930 | PubTator, text mining | PubMed |
| Ocular cues to a larger picture! | Indian J Ophthalmol | 2025 | 40434453 | PubTator, text mining | PubMed |
| Multimorbidity Through the Lens of the Eye: Pathogenic Variants for Multiple Systemic Disorders Found in an Autosomal Dominant Congenital Cataract Cohort. | Genes (Basel) | 2025 | 40428427 | PubTator, text mining | PubMed |
| Whole genome sequencing identifies monogenic disease in 56.1% of families with early-onset steroid-resistant nephrotic syndrome. | Hum Genet | 2025 | 40402239 | PubTator, text mining | PubMed |
| A case report of atypical autosomal dominant polycystic kidney disease presenting as glomerulocystic kidney superimposed with thin basement membrane nephropathy. | BMC Nephrol | 2025 | 40375172 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1285/papers?page=6